Novel views on new-onset diabetes after transplantation: development, prevention and treatment
Manfred Hecking(Medical University of Vienna), Akinlolu Ojo(Korea Advanced Institute of Science and Technology), M. D. Saemann(Medical University of Vienna), Adnan Sharif(Southeastern Community College - Iowa), Giovanni Pacini(National Research Council), Klemens Budde(Charité - Universitätsmedizin Berlin), Esteban Porrini(Universidad de La Laguna), Aiko P. J. de Vries(Leiden University Medical Center), Michael Haidinger(Medical University of Vienna), Johannes Werzowa(Medical University of Vienna), Julio Pascual(Pompeu Fabra University), Friedrich K. Port(Arbor Research Collaborative for Health), Fu L. Luan(Cornell University), Walter H. Hörl(Medical University of Vienna)
Cited by 122
Related Papers
The Chronic Renal Insufficiency Cohort (CRIC) Study
|Journal of the American Society of Nephrology|2003|650
Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2010|574
Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
|American Journal of Transplantation|2014|522
Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans
|Journal of Clinical Investigation|2010|516
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
|Nephrology Dialysis Transplantation|2013|472